Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • May 24, 2017
    OPDP Issues First 2017 Untitled Letter Over Misleading Risk Info in DTC TV Ad
  • May 23, 2017
    California Senate Approves Bill Clamping Down on Drug and Biologic Makers’ Gifts to Health Providers
  • May 22, 2017
    Nevada Senate Passes Bill Requiring Sales Rep. Reporting
  • May 20, 2017
    JAMA Viewpoint Calls for More Scrutiny of Disease Awareness Advertisements
  • May 20, 2017
    Fourth N.Y. County Sues Pharmaceutical Companies Over Opioid Marketing
  • May 19, 2017
    FDA Extends Intended Uses Rule Comment Period to July 18
  • May 18, 2017
    FAIR Drug Transparency Bill Re-introduced
  • May 15, 2017
    ‘Native Ads’ Require Close Scrutiny
  • May 12, 2017
    What’s In Store for the Gottlieb Era at FDA?
  • May 12, 2017
    CME Organizers Continue To Struggle With COI
  • More

Good Clinical Practice

  • Nov 21, 2017
    Gene Editing Trials Face Tough Ethical Questions
  • Nov 21, 2017
    Melanoma Exchange Provides Trial Info
  • Nov 18, 2017
    2018 Compilation of Human Research Standards Adds Four Nations, New Topic
  • Nov 14, 2017
    NIH Starts Data Commons Pilot
  • Nov 14, 2017
    Study Finds 45 Percent of EU Marketing Authorizations Based on Single Pivotal Trial
  • Nov 11, 2017
    FDA Awards Grants to Aid Pediatric Trial Development
  • Nov 11, 2017
    FDA Study Finds Trials Reporting Sex Data, But Minorities Are Still Under Represented
  • Nov 9, 2017
    Sponsors Need To Evaluate Drug Effects on Driving
  • Nov 6, 2017
    Lupus Foundation Study Finds New Model for Assessing Lupus Patient Outcomes
  • Nov 6, 2017
    SACHRP Recommends Research Categories for Expedited IRB Review
  • More

U.S. Food Labeling

  • Nov 30,2011
    WTO Panel Rules Against U.S.'s Mandatory COOL Law
  • Nov 30,2011
    California Files 'Greenwashing' Lawsuit Against Firms Making Biodegradability Claims
  • Nov 30,2011
    Ohio Agrees To Abandon Restrictive Labeling Regulation Involving 'rbGH Free' Claims
  • Nov 30,2011
    Public Health Group Urges Sodium Regulation by FDA
  • Nov 30,2011
    Federal Appeals Court Dismisses Fiber Suit Against Kellogg and General Mills
  • Nov 30,2011
    Product Recalls
  • Nov 30,2011
    Challenge to Food Product Labeling Preempted
  • Oct 31,2011
    FTC Tells Lawmakers It Will Revise Proposed Guidelines for Marketing Foods to Kids
  • Oct 31,2011
    Get Your Newsletter Faster Online!
  • Oct 31,2011
    Product Recalls
  • More

FDA Regulation & Enforcement

  • May 5, 2020
    N.Y. Goes After Mallinckrodt for Alleged Insurance Fraud Related to Opioid Marketing
  • Apr 30, 2020
    FDA Extends Comment Period on Principles for Food Standards Modernization
  • Apr 29, 2020
    Surgeon To Pay $1.75 Million for Receiving Kickbacks from Device Maker Through ‘Consulting’ Firm
  • Apr 28, 2020
    Los Angeles Reaches Agreements with Two Companies Over Marketing of COVID-19 Kits
  • Apr 22, 2020
    Chipotle To Pay Record $25 Million Criminal Fine, Enters into DPA To Resolve Food Adulteration Charges
  • Apr 20, 2020
    Court Issues Temporary Restraining Order Against Florida ‘Nonreligious Church’ Marketing COVID-19 ‘Cure’
  • Apr 20, 2020
    Physician Charged with Fraud for Selling COVID-19 'Miracle Cure'
  • Apr 16, 2020
    FSIS Says Product of USA Labeling May Be ‘Confusing,’ Will Initiate Rulemaking
  • Apr 15, 2020
    Fewer Doctors Are Prescribing Drugs Patients Request After Seeing DTC Ads
  • Apr 10, 2020
    FDA Shifts to Remote FSVP Inspections Due to COVID-19, Will Ask Food Importers To Submit Records
  • More

Medical Devices

  • Jul 16, 2014
    Draft Guidance Outlines Benefit, Risk Factors in Substantial Equivalence Reviews of New Technology
  • Jul 10, 2014
    Senators Call on OMB To Release Draft FDA Guidance on Laboratory-Developed Diagnostic Tests
  • Jun 30, 2014
    FDA Outlines Overall Approach to Nanotechnology
  • Jun 27, 2014
    Supreme Court Will Not Review Ninth Circuit Ruling That Failure-To-Warn Claim Is Not Preempted
  • Jun 25, 2014
    Agency Releases Complete Final GUDID Guidance
  • Jun 25, 2014
    Complete Final GUDID Guidance Document Is Released
  • Jun 23, 2014
    Supreme Court Will Not Review Ninth Circuit Ruling That Failure-To-Warn Claim Is Not Preempted
  • Jun 20, 2014
    FDA Plans Not To Enforce Regulatory Controls for Medical Device Data Systems, Citing ‘Critical’ Need
  • Jun 13, 2014
    CDRH Sets ‘Plan of Action’ in Response to Independent Study of Device Submission Review Procedures
  • Jun 13, 2014
    More Regulatory Challenges — and Some Real Opportunities — Emerge for Device Companies
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.